CU

Christian Uhrich

Investments at M Ventures

Karlsruhe, Baden-Württemberg

Overview

Work Experience

MV

M Ventures

  • Investment Director, Biotechnology Investments

    2021 - Current

  • Head of Strategy

    2019 - 2021

L

LabGenius

  • Board Observer

    2024

IM

Indi Molecular

  • Member Board of Directors

    2023

C

CellFE

  • Member Board of Directors

    2023

I

Iktos

  • Board Observer

    2023

LD

Lightcast Discovery

  • Member Board of Directors

    2022

A

Astraveus

  • Member Board of Directors

    2022

DS

DNA Script

  • Board Observer

    2022

Sb

Scipio bioscience

  • Board Observer

    2022

Riffyn

  • Member Board of Directors

    2021 - 2022

    Riffyn was acquired by Siemens and integrated into the Siemens Life Science offerings as Riffyn X in 2022.

Education

Relevant Websites